2023 annual financial data
Corbus Pharmaceuticals Holdings 2023 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -45.08M USD and net income was -44.6M USD.
Operating cash flow was -36.1M USD.
Get free Corbus Pharmaceuticals Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -45.08M USD
- Net income
- -44.6M USD
- Operating cash flow
- -36.1M USD
Explore related company data
View all 2023 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Corbus Pharmaceuticals Holdings financial years